di(2-propanoyloxyethyl)methylamine | 91241-84-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: di(2-propanoyloxyethyl)methylamine
• 英文别名: methyl-bis-(2-propionyloxy-ethyl)-amine；Methyl-bis-(2-propionyloxy-aethyl)-amin；Di(2-propan-oyloxyethyl)methylamine；2-[methyl(2-propanoyloxyethyl)amino]ethyl propanoate
• CAS: 91241-84-8
• 化学式: C₁₁H₂₁NO₄
• 分子量: 231.292
• InChiKey: UGDMDSQJPUDXDA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  16
• 可旋转键数：
  10
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  55.8
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  N-甲基二乙醇胺 、 丙酸酐 生成 di(2-propanoyloxyethyl)methylamine
  参考文献：
  名称：

  New Compounds. N-Methyl-di-B-propionyloxyethylamine

  摘要：

  DOI：

  10.1021/ja01128a075

文献信息

• Synthesis of N-Substituted Oxazolidines and Morpholines
  作者：A. M. Magerramov、M. N. Magerramov、Kh. A. Makhmudova、G. I. Alizade

  DOI：10.1007/s11167-005-0502-x

  日期：2005.8

  A series of N-substituted oxazolidines and morpholines were prepared and characterized.

  一系列N-取代的噁唑烷和吗啉被制备并进行了表征。
• Chain transfer agents for raft polymerization in aqueous media
  申请人：McCormick L. Charles

  公开号：US20070123670A1

  公开（公告）日：2007-05-31

  Polymers and copolymers synthesized by means that yield a narrow range of molecular weights can have different properties than polymers synthesized by conventional means. In order to obtain such polymers, however, polymerization must be controlled. One type of controlled polymerization is the reversible addition-fragmentation chain transfer (RAFT) process, which has characteristics of a living polymerization. The present invention discloses a group of dithioesters and trithioesters suitable as chain transfer agents for RAFT polymerization. The present invention also discloses RAFT polymerizations conducted in aqueous media.

  通过产生分子量窄范围的手段合成的聚合物和共聚物可能具有不同于传统手段合成的聚合物的性质。然而，为了获得这种聚合物，聚合必须受到控制。一种受控聚合的类型是可逆加成-断裂链转移（RAFT）过程，具有活性聚合的特征。本发明揭示了一组二硫代酯和三硫代酯，适用于RAFT聚合的链转移剂。本发明还揭示了在水介质中进行的RAFT聚合。
• Method for Making Waterborne Polyurethane with a Reactive Functional Group and a Nanocomposite Made of the Same
  申请人：Su Wen-Chiung

  公开号：US20130131301A1

  公开（公告）日：2013-05-23

  Disclosed is a method for making waterborne polyurethane with a reactive functional group. The method includes the step of introducing a short-chain diol monomer with a reactive functional group into waterborne polyurethane polymer by pre-polymerization to provide a polyurethane pre-polymer with the reactive functional group connected to a side chain and the step of reacting the pre-polymer with hydrophilic diamine for chain extension and inter-crosslink to provide waterborne polyurethane with different crosslink degree. The short-chain diol monomer is expressed by structural formula (I) and the polyurethane pre-polymer with the reactive functional group connected to the side chain is expressed by structural formula (II) as follows: A is azetidine-2,4-dione functional group or malonamide-linked alkyl group and B is nitrogen-linked di-hydroxy terminal group or tertiary amine-linked di-hydroxy terminal group R1 is diisocyanate, and R2 is a polyol backbone and wherein IG is a neutralized ionic group.
• US20140343224A1
  申请人：——

  公开号：US20140343224A1

  公开（公告）日：2014-11-20
• POLYAMINE-FATTY ACID DERIVED LIPIDOIDS AND USES THEREOF
  申请人：Massachusetts Institute of Technology

  公开号：US20160002178A1

  公开（公告）日：2016-01-07

  The present disclosure provides polyamine-fatty acid derived lipidoids (e.g., compounds of Formula (I) or (II)) and methods of preparing the lipidoids. A described lipidoid includes R—C(═O)—O— moieties (where R is a lipid moiety), which may be hydrolyzed into non-toxic fatty acids. Also provided are compositions including a described lipidoid and an agent (e.g., polynucleotide, small molecule, peptide, or protein). The present disclosure also provides methods, kits, and uses that involve the lipidoids or compositions for delivering an agent to a subject, tissue, or cell and/or for treating and/or preventing a range of diseases, such as genetic diseases, proliferative diseases, hematological diseases, neurological diseases, immunological diseases, gastrointestinal diseases, respiratory diseases, painful conditions, psychiatric disorders, and metabolic disorders.